Neurobiology of AgingNeurosciencePeer-reviewed journal article
Systemic infections alter cortical transcriptional signatures in Alzheimer's disease
Giulia PegoraroiD, Lachlan Ford MacBean, Adam R. SmithiD, Darren M. SoanesiD, Rebecca G. SmithiD, Jennifer L. ImmiD, Joshua HarveyiD, Morteza P KouhsariD, Valentin LarocheiD, Luke Stephen WeymouthiD, Isabel CastanhoiD, Winston HideiD, Laura Palmer, Debra J. Lett, Andrew RobinsoniD, Natalie L. Woodman, Karina McDadeiD, Delphine BocheiD, Ehsan PishvaiD, Katie LunnoniD
Abstract
Alzheimers disease (AD) is characterized by neuroinflammation, yet the impact of concurrent systemic infections on the AD brain remains poorly understood. We investigated the molecular mechanisms underlying the central nervous system response to systemic infections in AD by analyzing RNA sequencing data generated in the prefrontal cortex from 202 post-mortem donors (113 AD, 89 controls), where we stratified by the presence of a respiratory infection at the time of death. We identified 763 significantly differentially expressed genes (DEGs) between AD and controls without infection, which were enriched for oxidative phosphorylation and neurodegenerative pathways. In contrast, 122 DEGs distinguished AD from controls during infection, with 57 genes uniquely altered in AD in the presence of infection, including MAPK4, VAV3, and POU3F4, implicating infection-dependent mechanisms of vascular and immune regulation. Pathway activity analysis revealed that infection in AD suppresses some immune and vascular pathways, while enhancing transcriptional and developmental programs. Weighted gene co-expression network analysis uncovered three key modules: one module strongly associated with AD, enriched for aging and signal transduction; one module linked to both AD and infection, highlighting cytoskeletal remodelling and host-pathogen interactions; and one module specific to infection, enriched in astrocytes, pericytes, and endothelial cells, implicating blood-brain barrier dysfunction. These findings suggest that systemic respiratory infections reshape transcriptional programs in the AD brain, dampening immune effector pathways and engaging vascular and host-pathogen processes in blood-brain-barrier-associated cell types. Our results highlight the complex interplay between systemic infection, neuroinflammation, and vascular responses in AD.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 1
- FWCI
- 2.79
- Field percentile
- top 17%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prefrontal cortex transcriptomes distinguish Alzheimers disease from asymptomatic amyloid pathology, neuropeptide loss, immune-complement activation and glial remodelling
Yusuf Aliyu Munir, Umar Sagir, … Ibrahim Maikudi Sani·bioRxiv·Nov 2, 2026
- Genetic,transcriptome, proteomic and epidemiological evidence for blood brain barrier disruption and polymicrobial brain invasion as determinant factors in Alzheimers disease.
Christopher J. Carter·Journal of Alzheimer s Disease ReportsPeer-reviewed·Sep 25, 2017
- Transcriptomic signatures of Abeta- and tau-induced neuronal dysfunction reveal inflammatory processes at the core of Alzheimer's disease pathophysiology
Lazaro M. Sanchez-Rodriguez, Ahmed Faraz Khan, … Yasser Iturria‐Medina·bioRxiv·Sep 15, 2023
- Weakly activated core inflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer's disease
Fuhai Li, Abdallah M. Eteleeb, … Carlos Cruchaga·bioRxiv·Aug 30, 2021
- Systems genetic dissection of Alzheimer's disease brain gene expression networks
Pinghan Zhao, Omar El Fadel, … Joshua M Shulman·bioRxiv·Oct 4, 2024
- Multi-scale transcriptomic integration reveals cell-type immune networks and lncRNA remodeling in Alzheimers disease
Jonathan Alexis Cortes Silva, Michael Gertig, … André Fischer·bioRxiv·Feb 10, 2026